Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 8/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20419963 | 0.91 | KAT2B (0.70) | KAT2BMAPTLMNAPKMRAB9A | |
| SCHEMBL29737974 | 0.83 | LMNA (0.63) | KAT2BMAPTLMNAPKMRAB9A | |
| SCHEMBL20571599 | 0.83 | LMNA (0.63) | KAT2BMAPTLMNAPKMRAB9A | |
| Hydrochloric Acid SCHEMBL515537 | 0.83 | KAT2B (0.81) | KAT2BMAPTLMNAPKMRAB9A | |
| SCHEMBL20420165 | 0.80 | MAPT (0.58) | KAT2BMAPTLMNAPKMRAB9A | |
| SCHEMBL20419976 | 0.79 | KAT2B (0.60) | KAT2BMAPTLMNAPKMRAB9A | |
| SCHEMBL22126304 | 0.79 | HCAR3 (0.57) | KAT2BMAPTLMNAALDH1A1 | |
| SCHEMBL20420121 | 0.79 | MAPT (0.53) | KAT2BMAPTLMNARAB9ASMN1; SMN2 | |
| SCHEMBL7371227 | 0.78 | RAB9A (0.61) | KAT2BMAPTLMNAPKMRAB9A | |
| SCHEMBL740421 | 0.78 | KAT2B (0.56) | KAT2BMAPTLMNAPKMRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200199174-A1 | NOVEL FLUORESCENT LABELING METHOD | THE UNIVERSITY OF TOKYO (JP) | 2020-06-25 | — | — | US | disclosed |
| US-20200199174-A1 | NOVEL FLUORESCENT LABELING METHOD | THE UNIVERSITY OF TOKYO (JP) | 2020-06-25 | — | — | US | disclosed |
| WO-2018135598-A1 | NOVEL FLUORESCENT LABELING METHOD | 国立大学法人 東京大学 | 2018-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199174-A1 | NOVEL FLUORESCENT LABELING METHOD | RPS27A, DNPEP, DNM1L | KAT2B 2802/4885MAPT 1510/4885LMNA 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.